Locations:

Tag: manmeet ahluwalia

June 25, 2020/Cancer/Research

Phase II Trial Evaluates Safety of Pembrolizumab plus SurVaxM in Recurrent Glioblastoma

Will cancer vaccine boost immunotherapy’s efficacy?

November 2, 2018/Basic & Translational Science

Taking on Glioblastoma Through Translational Research: 4 Promising Bench-to-Bedside Initiatives

Rationale and status reports on mechanistically diverse strategies

18-NEU-4010-glioblastoma-laser-ablation-650×450

September 17, 2018/Cancer

Tumor Ablation with Chemo-Radiotherapy Consolidation Yields Rare Durable Glioblastoma Remission

No evidence of residual tumor or recurrence at 6.5 years of follow-up

June 2, 2018/Cancer/Research

Immunotherapy Vaccine Improves Survival Rates in Patients with Glioblastoma

Drug stimulates an immune response to survivin

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

January 15, 2018/Cancer

Survival Benefit of Adjunctive Tumor-Treating Fields Therapy Confirmed in Glioblastoma

First new medical intervention in a decade to demonstrate improved survival

June 4, 2017/Cancer/Research

Maximum Tolerable Doses for Adding Cell Checkpoint Inhibitor to Standard of Care for Glioblastoma Patients

Inhibitor stops DNA repair of cancer cells

BackPage 1 of 1Next